PIAZZA ROCCO GIOVANNI

Role
Associate professor  
Academic disciplines
Malattie del sangue (MED/15)
Office phone
Room:
  • U08, Floor: 4, Room: 4043
  • U08, Floor: 4, Room: LABORATORIO 4.10

Publications

  • Elli, E., Mauri, M., D’Aliberti, D., Crespiatico, I., Fontana, D., Redaelli, S., et al. (2024). Idiopathic erythrocytosis: a germline disease?. CLINICAL AND EXPERIMENTAL MEDICINE, 24(1) [10.1007/s10238-023-01283-y]. Detail

  • Villa, M., Malighetti, F., Sala, E., Sharma, G., Arosio, G., Gemelli, M., et al. (2024). New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients. NPJ PRECISION ONCOLOGY, 8(1) [10.1038/s41698-024-00498-w]. Detail

  • Giatti, S., Cioffi, L., Diviccaro, S., Piazza, R., Melcangi, R. (2024). Analysis of the finasteride treatment and its withdrawal in the rat hypothalamus and hippocampus at whole-transcriptome level. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION [10.1007/s40618-024-02345-y]. Detail

  • Crippa, V., Fina, E., Ramazzotti, D., Piazza, R. (2024). Control-FREEC viewer: a tool for the visualization and exploration of copy number variation data. BMC BIOINFORMATICS, 25(1) [10.1186/s12859-024-05694-w]. Detail

  • Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD [10.1182/blood.2023021349]. Detail

Research projects

Towards new therapeutic approaches for the treatment of SETBP1-driven leukemias - I annualità
Year: 2023
Grantors: FONDAZIONE AIRC
Characterization of the somatic and germline mutation landscape of Triple Negative Myeloproliferative Neoplasms - V annualità
Year: 2022
Grantors: FONDAZIONE AIRC
Characterization of the somatic and germline mutation landscape of Triple Negative Myeloproliferative Neoplasms - IV annualità
Year: 2021
Call: 2018-003 - Investigator Grant - Call for proposal 2018
Grantors: FONDAZIONE AIRC
Development and preclinical testing in human cell models and transgenic mice of a novel treatment for Schinzel – Giedion Syndrome
Year: 2021
Grantors: UNIONE EUROPEA
Longitudinal analysis of single cell data for hematopoietic stem-cell identification
Year: 2021
Call: FAQC 2021 - terza finestra
Grantors: Università degli Studi di MILANO-BICOCCA

Awards

Awards

  • Premio Fondazione Bruno Farmaceutici 2014, Fondazione Bruno Farmaceutici, 2014